New hope: boosting chemo with immune drug before breast cancer surgery

NCT ID NCT04243616

Summary

This study is testing if adding an immunotherapy drug called cemiplimab to standard chemotherapy before surgery works better for certain high-risk breast cancers. It will involve 36 women with locally advanced breast cancer that tests positive for specific markers. The main goal is to see if this combination helps eliminate more cancer from the breast and lymph nodes by the time of surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Froedtert Hospital & Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

Conditions

Explore the condition pages connected to this study.